ASIT Biotech Receives GMP Certification for Its Manufacturing Site in Liège, Belgium
October 07, 2019 at 01:00 am EDT
ASIT Biotech S.A. received the Good Manufacturing Practices (GMP) certification for its manufacturing site in Liège, Belgium, from the Federal Agency for Medicines and Health Products (FAMHP). The certification follows a 2-day site inspection from the FAMHP and the constructive dialogue with the Agency. It allows ASIT biotech to manufacture in-house the active pharmaceutical ingredient of its leading product for grass pollen allergies under GMP-compliant conditions for future clinical and commercial use.